article · International Journal of Islamic and Complementary Medicine
This study aimed to explore the effectiveness of the Alfasdh (BA) method in the treatment of various diseases through an observational clinical study. The study was conducted from April 2023–April 2024 on 35 outpatients divided into neurological (n=18) and surgical (n=17) groups, with evaluation of quality of life (EQ-5D-Y-5L) and pain (VAS) before, during, and after therapy. The results showed no significant difference in quality of life between groups, as well as no significant difference in pain during therapy, but there was a significant difference after therapy, indicating greater improvement in the neurological group. Overall, BA has the potential to provide clinical benefits, especially in neurological cases, although further research with a larger sample size and longer follow-up is needed to confirm its long-term effectiveness.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.55116/ijicm.v7i1.107
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
